Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment

Omer Trivizki, Liang Wang, Prashanth Iyer, Yingying Shi, Philip J. Rosenfeld, David Rabinovitch, Justin Townsend

Research output: Contribution to journalArticlepeer-review

Abstract

A rare occurrence of bilateral peripapillary choroidal neovascularization (CNV) in an 18-year-old idiopathic intracranial hypertension (IIH) patient regressed with systemic acetazolamide treatment alone. Multimodal imaging was done, including OCT angiography (OCTA), which showed CNV. No injections were given even though she had macular fluid in her left eye. Nonetheless, the subretinal fluid resolved, and visual acuity improved. This report shows that CNV secondary to IIH can be managed with systemic therapy alone. Moreover, we showed for the first time the ability to diagnose IIH-associated CNV using OCTA.

Original languageEnglish
Pages (from-to)270-275
Number of pages6
JournalCase Reports in Ophthalmology
DOIs
StateAccepted/In press - 2022

Keywords

  • Acetazolamide
  • Idiopathic intracranial hypertension
  • Multimodal imaging
  • Optical coherence tomography angiography angiography
  • Peripapillary choroidal neovascularization
  • Vascular endothelial growth factor

Fingerprint

Dive into the research topics of 'Regression of Bilateral Peripapillary Choroidal Neovascularization Associated with Idiopathic Intracranial Hypertension after Systemic Acetazolamide Treatment'. Together they form a unique fingerprint.

Cite this